LOC105369308: A Drug Target / Disease Biomarker (G105369308)
LOC105369308: A Drug Target / Disease Biomarker
LOC105369308 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the superfamily of G-coupled proteins, which are a type of transmembrane protein that consists of a catalytic subunit and a transmembrane region.
The protein encoded by LOC105369308 is approximately 15 kilodalton (kDa) in size and has a calculated pI of approximately 6.5. It is expressed in a variety of tissues and has been shown to play a role in several physiological processes, including cell signaling, inflammation, and metabolism.
One of the most promising aspects of LOC105369308 is its potential as a drug target. Due to its widespread expression and its role in several important biological processes, LOC105369308 has been identified as a promising candidate for targeting with small molecules, antibodies, or other therapeutic agents.
In addition to its potential as a drug target, LOC105369308 has also been shown to be a valuable biomarker for several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This makes it an attractive target for researchers who are looking for new diagnostic or therapeutic approaches.
The studies that have been performed on LOC105369308 have primarily focused on its role in cell signaling and its potential as a drug target. One of the most significant findings of these studies is that LOC105369308 is a critical regulator of the TGF-β signaling pathway. TGF-β is a well-known protein that plays a role in cell signaling and is involved in several important processes, including cell growth, differentiation, and inflammation.
Research has shown that LOC105369308 is a negative regulator of TGF-β signaling, which means that it works to inhibit the activity of TGF-β. This is important because TGF-β is often associated with the development and progression of many diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. By targeting LOC105369308 with small molecules or antibodies, researchers may be able to reduce the activity of TGF-β and potentially inhibit the development of these diseases.
Another potential mechanism by which LOC105369308 may be involved in disease is its role in inflammation. LOC105369308 has been shown to be involved in the regulation of the immune response and has been implicated in the development of autoimmune disorders. Additionally, LOC105369308 has also been shown to play a role in the regulation of inflammation, which may contribute to its potential as a therapeutic agent for diseases that are characterized by chronic inflammation.
In addition to its potential as a drug target or biomarker, LOC105369308 has also been shown to have several other physiological functions. For example, it is involved in the regulation of cell adhesion, which is important for the development and maintenance of tissues and organs. Additionally, LOC105369308 is involved in the regulation of cell survival, which is important for the growth and maintenance of tissues and organs.
Overall, LOC105369308 is a protein that has significant potential as a drug target or biomarker. Its role as a negative regulator of TGF-β signaling, its involvement in cell signaling and inflammation, and its role in cell adhesion and survival make it an attractive candidate for targeting with small molecules, antibodies, or other therapeutic agents. Further research is needed to fully understand the
Protein Name: Uncharacterized LOC105369308
The "LOC105369308 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105369308 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
LOC105369309 | LOC105369312 | LOC105369315 | LOC105369325 | LOC105369326 | LOC105369366 | LOC105369367 | LOC105369368 | LOC105369380 | LOC105369384 | LOC105369388 | LOC105369391 | LOC105369395 | LOC105369401 | LOC105369410 | LOC105369441 | LOC105369455 | LOC105369456 | LOC105369464 | LOC105369501 | LOC105369506 | LOC105369513 | LOC105369530 | LOC105369531 | LOC105369566 | LOC105369568 | LOC105369572 | LOC105369574 | LOC105369603 | LOC105369612 | LOC105369614 | LOC105369617 | LOC105369623 | LOC105369625 | LOC105369628 | LOC105369639 | LOC105369645 | LOC105369655 | LOC105369663 | LOC105369689 | LOC105369698 | LOC105369705 | LOC105369709 | LOC105369710 | LOC105369732 | LOC105369735 | LOC105369736 | LOC105369743 | LOC105369749 | LOC105369750 | LOC105369761 | LOC105369765 | LOC105369772 | LOC105369775 | LOC105369777 | LOC105369780 | LOC105369781 | LOC105369798 | LOC105369806 | LOC105369818 | LOC105369823 | LOC105369830 | LOC105369833 | LOC105369835 | LOC105369838 | LOC105369843 | LOC105369844 | LOC105369850 | LOC105369862 | LOC105369869 | LOC105369879 | LOC105369890 | LOC105369896 | LOC105369923 | LOC105369927 | LOC105369928 | LOC105369944 | LOC105369958 | LOC105369965 | LOC105369976 | LOC105369998 | LOC105370002 | LOC105370003 | LOC105370011 | LOC105370025 | LOC105370027 | LOC105370032 | LOC105370050 | LOC105370073 | LOC105370076 | LOC105370108 | LOC105370109 | LOC105370113 | LOC105370115 | LOC105370127 | LOC105370128 | LOC105370134 | LOC105370135 | LOC105370165 | LOC105370168
